Hyperuricemia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Hyperuricemia refers to an elevated concentration of uric acid in the bloodstream, with levels surpassing the standard upper limit of 6.8mg/dL. When uric acid content reaches 7 mg/dL or more, it is considered to be saturated, and this can lead to the emergence of symptoms. This elevation in uric acid arises from an excess production of uric acid, a reduced ability to eliminate uric acid or a combination of these two processes. The elevated uric acid levels can also be observed in conditions involving rapid breakdown of cells, such as hemolysis, rhabdomyolysis, and tumor lysis, which lead to accelerated purine degradation. Additionally, reduced excretion of uric acid can result from issues like renal insufficiency and metabolic acidosis. Hyperuricemia is linked to the development of gout, a condition characterized by the accumulation of uric acid in the blood and tissues, as well as nephrolithiasis (formation of kidney stones). Urate Overproduction: Consumption of diets rich...